Literature DB >> 30793785

Outcomes of surgical treatment for hemangiomas.

Jeffrey Cheng1, Beiyu Liu2, Hui-Jie Lee2.   

Abstract

OBJECTIVE: To quantify complications and rates of adverse events associated with surgical excision of hemangiomas in children using a national surgical database. DATA SOURCE: Pediatric American College of Surgeons (ACS) National Surgical Quality Improvement Program® (ACS NSQIP® -pediatric), years 2012-2016.
METHODS: Subjects included children under 18 years with a postoperative diagnosis of International Classification of Diseases (ICD), 9th revision code: 228.00 and 228.01, or ICD 10 codes D18.00 and D18.01-hemangioma, any site and hemangioma, of skin and subcutaneous tissue.
RESULTS: A total of 1180 patients were included. The median age was 3.2 years (interquartile range [IQR] 1.2 to 6.4 years old). No occurrences of deep incisional surgical site infection, nerve injury, mortality, sepsis, septic shock, or blood stream infections were noted. In multivariate analysis, age ≤ 3 years and advanced American Society of Anesthesiologists class were significant predictors of adverse events (P = 0.035 and 0.001, respectively).
CONCLUSIONS: For children with infantile hemangioma who fail to respond or have an incomplete response to medical therapy, surgical resection may be a relatively safe treatment alternative. Children older than 3 years of age with hemangiomas had less surgical adverse events than younger children. Overall, however, the surgical complications rates were low and deemed relatively minor.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  National Surgical Quality Improvement Program; complications; hemangioma; surgery; vascular anomalies

Mesh:

Year:  2019        PMID: 30793785      PMCID: PMC6428594          DOI: 10.1111/pde.13751

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  12 in total

1.  Diagnosis and Management of Infantile Hemangioma: Executive Summary.

Authors:  David H Darrow; Arin K Greene; Anthony J Mancini; Amy J Nopper
Journal:  Pediatrics       Date:  2015-10       Impact factor: 7.124

2.  Infantile Hemangiomas of the Lip: Patterns, Outcomes, and Implications.

Authors:  Daniel A Yanes; Gregory D Pearson; Patricia M Witman
Journal:  Pediatr Dermatol       Date:  2016-07-11       Impact factor: 1.588

3.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

Review 4.  Infantile hemangiomas, complications and treatments.

Authors:  Carol Erin Cheng; Sheila Fallon Friedlander
Journal:  Semin Cutan Med Surg       Date:  2016-09

5.  A randomized, controlled trial of oral propranolol in infantile hemangioma.

Authors:  Christine Léauté-Labrèze; Peter Hoeger; Juliette Mazereeuw-Hautier; Laurent Guibaud; Eulalia Baselga; Gintas Posiunas; Roderic J Phillips; Hector Caceres; Juan Carlos Lopez Gutierrez; Rosalia Ballona; Sheila Fallon Friedlander; Julie Powell; Danuta Perek; Brandie Metz; Sebastien Barbarot; Annabel Maruani; Zsuzsanna Zsofia Szalai; Alfons Krol; Olivia Boccara; Regina Foelster-Holst; Maria Isabel Febrer Bosch; John Su; Hana Buckova; Antonio Torrelo; Frederic Cambazard; Rainer Grantzow; Orli Wargon; Dariusz Wyrzykowski; Jochen Roessler; Jose Bernabeu-Wittel; Adriana M Valencia; Przemyslaw Przewratil; Sharon Glick; Elena Pope; Nicholas Birchall; Latanya Benjamin; Anthony J Mancini; Pierre Vabres; Pierre Souteyrand; Ilona J Frieden; Charles I Berul; Cyrus R Mehta; Sorilla Prey; Franck Boralevi; Caroline C Morgan; Stephane Heritier; Alain Delarue; Jean-Jacques Voisard
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

Review 6.  The changing face of complicated infantile hemangioma treatment.

Authors:  Deanna Menapace; Mario Mitkov; Richard Towbin; Marcia Hogeling
Journal:  Pediatr Radiol       Date:  2016-07-23

Review 7.  Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis.

Authors:  Sivakumar Chinnadurai; Christopher Fonnesbeck; Kristen M Snyder; Nila A Sathe; Anna Morad; Frances E Likis; Melissa L McPheeters
Journal:  Pediatrics       Date:  2016-01-15       Impact factor: 7.124

Review 8.  Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review.

Authors:  Christine Léaute-Labrèze; Olivia Boccara; Caroline Degrugillier-Chopinet; Juliette Mazereeuw-Hautier; Sorilla Prey; Geneviève Lebbé; Stéphanie Gautier; Valérie Ortis; Martine Lafon; Agnès Montagne; Alain Delarue; Jean-Jacques Voisard
Journal:  Pediatrics       Date:  2016-10       Impact factor: 7.124

9.  Surgical Treatment of Facial Infantile Hemangiomas: An Analysis Based on Tumor Characteristics and Outcomes.

Authors:  Dov C Goldenberg; Patricia Y Hiraki; Tatiana Moura Marques; Andrea Koga; Rolf Gemperli
Journal:  Plast Reconstr Surg       Date:  2016-04       Impact factor: 4.730

10.  Analysis of factors affecting the therapeutic effect of propranolol for infantile haemangioma of the head and neck.

Authors:  Jian-Yong Dong; Jie-Xin Ning; Kai Li; Chao Liu; Xu-Xia Wang; Rong-Hui Li; Lin-Lin Yue; Ying-Ying Huang; Shao-Hua Liu
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

View more
  1 in total

1.  Treatment of superficial benign vascular tumors by high intensity focused ultrasound: Observations in two illustrative cases.

Authors:  Jacek Calik; Tomasz Zawada; Torsten Bove
Journal:  J Cosmet Dermatol       Date:  2021-12-17       Impact factor: 2.189

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.